about
Role of opioid receptors in neurogenic dural vasodilation and sensitization of trigeminal neurones in anaesthetized ratsThe delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization.The opioid growth factor-opioid growth factor receptor axis regulates cell proliferation of human hepatocellular cancerSingle potassium channels opened by opioids in rat locus ceruleus neurons.Central non-opioid physiological and pathophysiological effects of dynorphin A and related peptides.Regulation of Tenon's capsule fibroblast cell proliferation by the opioid growth factor and the opioid growth factor receptor axis.Inhibitory effects of certain enantiomeric cannabinoids in the mouse vas deferens and the myenteric plexus preparation of guinea-pig small intestine.Delta-opioid receptor binding sites in rodent spinal cord.Antagonist, partial agonist and antiproliferative actions of B-9870 (CU201) as a function of the expression and density of the bradykinin B1 and B2 receptorsThe OGF-OGFr axis utilizes the p21 pathway to restrict progression of human pancreatic cancerDiscriminative stimulus properties of naloxone in Long-Evans rats: assessment with the conditioned taste aversion baseline of drug discrimination learningEffects of intrathecal SNC80, a delta receptor ligand, on nociceptive threshold and dorsal horn substance p release.2',6'-dimethylphenylalanine: a useful aromatic amino Acid surrogate for tyr or phe residue in opioid peptides.Identification of putative insect brush border membrane-binding molecules specific to Bacillus thuringiensis delta-endotoxin by protein blot analysis.Activity profiles of dalargin and its analogues in mu-, delta- and kappa-opioid receptor selective bioassays.Enhancement of retinal acetylcholine release by DAMGO: possibly a direct opioid receptor-mediated excitatory effectEffects of sigma ligands on the cloned mu-, delta- and kappa-opioid receptors co-expressed with G-protein-activated K+ (GIRK) channel in Xenopus oocytes.and Pharmacological Activities of 14--Phenylpropyloxymorphone, a Potent Mixed Mu/Delta/Kappa-Opioid Receptor Agonist With Reduced Constipation in Mice
P2860
Q28343904-587F79C0-4746-4B95-99A6-FC51A6C404AFQ30800519-D5468951-607C-4B14-A570-349723A131D0Q33686632-EB9FB624-2927-4DBF-A81D-342F58B18DFEQ33855070-DFA2A396-4B5A-4C5A-A1DF-D044D2D7B832Q33921068-C1FFE487-3E36-4260-9026-ADE35C1EAF0BQ34735305-141EF469-034F-4D62-B45D-2D1F1DF1A3C7Q35872513-8DB9FF03-D93B-489E-A3D2-152090CCE2C8Q35887875-30193900-B9CC-4FAE-8B1A-B991C7D0F12EQ36052584-86DEC4F3-B8EF-4A6B-A278-AA7A78037EABQ36477169-B001ACA6-22B4-4335-AABB-29D543F571EAQ37129992-7BDC29FC-E7DF-45D1-9252-0B684304A812Q37252030-A11A4D14-7944-46BE-9E42-B3B2DE4AE967Q38466895-369EB379-65F9-41EA-88DD-6F891D4153C2Q41895476-ED324A45-3F04-418C-8E25-BC60EDD74317Q42095523-AF75E811-F19B-44A8-8074-BC64D32ACF3DQ42102705-38C42FBE-2FF6-42D4-93E5-293F079E3B74Q42582270-65374397-A15B-4729-9EBC-3754BAF6CFA8Q57095558-D5B2C31E-7AF5-4B9C-BD4C-31D425E3D02C
P2860
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Methods used for the study of opioid receptors.
@en
Methods used for the study of opioid receptors.
@nl
type
label
Methods used for the study of opioid receptors.
@en
Methods used for the study of opioid receptors.
@nl
prefLabel
Methods used for the study of opioid receptors.
@en
Methods used for the study of opioid receptors.
@nl
P1476
Methods used for the study of opioid receptors.
@en
P2093
P304
P577
1987-09-01T00:00:00Z